654 related articles for article (PubMed ID: 8698873)
1. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma.
Palinski W; Hörkkö S; Miller E; Steinbrecher UP; Powell HC; Curtiss LK; Witztum JL
J Clin Invest; 1996 Aug; 98(3):800-14. PubMed ID: 8698873
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins.
Hörkkö S; Bird DA; Miller E; Itabe H; Leitinger N; Subbanagounder G; Berliner JA; Friedman P; Dennis EA; Curtiss LK; Palinski W; Witztum JL
J Clin Invest; 1999 Jan; 103(1):117-28. PubMed ID: 9884341
[TBL] [Abstract][Full Text] [Related]
3. Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein.
Hörkkö S; Miller E; Dudl E; Reaven P; Curtiss LK; Zvaifler NJ; Terkeltaub R; Pierangeli SS; Branch DW; Palinski W; Witztum JL
J Clin Invest; 1996 Aug; 98(3):815-25. PubMed ID: 8698874
[TBL] [Abstract][Full Text] [Related]
4. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum.
Palinski W; Ord VA; Plump AS; Breslow JL; Steinberg D; Witztum JL
Arterioscler Thromb; 1994 Apr; 14(4):605-16. PubMed ID: 7511933
[TBL] [Abstract][Full Text] [Related]
5. Circulating autoantibodies recognizing peroxidase-oxidized low density lipoprotein. Evidence for new antigenic epitopes formed in vivo independently from lipid peroxidation.
Seccia M; Albano E; Maggi E; Bellomo G
Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):134-40. PubMed ID: 9012648
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
Gounopoulos P; Merki E; Hansen LF; Choi SH; Tsimikas S
Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649
[TBL] [Abstract][Full Text] [Related]
7. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL.
Ylä-Herttuala S; Palinski W; Butler SW; Picard S; Steinberg D; Witztum JL
Arterioscler Thromb; 1994 Jan; 14(1):32-40. PubMed ID: 7506053
[TBL] [Abstract][Full Text] [Related]
8. Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes.
Freigang S; Hörkkö S; Miller E; Witztum JL; Palinski W
Arterioscler Thromb Vasc Biol; 1998 Dec; 18(12):1972-82. PubMed ID: 9848892
[TBL] [Abstract][Full Text] [Related]
9. Human-derived anti-oxidized LDL autoantibody blocks uptake of oxidized LDL by macrophages and localizes to atherosclerotic lesions in vivo.
Shaw PX; Hörkkö S; Tsimikas S; Chang MK; Palinski W; Silverman GJ; Chen PP; Witztum JL
Arterioscler Thromb Vasc Biol; 2001 Aug; 21(8):1333-9. PubMed ID: 11498462
[TBL] [Abstract][Full Text] [Related]
10. Human monoclonal Fab and human plasma antibodies to carbamyl-epitopes cross-react with malondialdehyde-adducts.
Kummu O; Turunen SP; Prus P; Lehtimäki J; Veneskoski M; Wang C; Hörkkö S
Immunology; 2014 Mar; 141(3):416-30. PubMed ID: 24168430
[TBL] [Abstract][Full Text] [Related]
11. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein.
Palinski W; Ylä-Herttuala S; Rosenfeld ME; Butler SW; Socher SA; Parthasarathy S; Curtiss LK; Witztum JL
Arteriosclerosis; 1990; 10(3):325-35. PubMed ID: 1693068
[TBL] [Abstract][Full Text] [Related]
12. Low density lipoprotein undergoes oxidative modification in vivo.
Palinski W; Rosenfeld ME; Ylä-Herttuala S; Gurtner GC; Socher SS; Butler SW; Parthasarathy S; Carew TE; Steinberg D; Witztum JL
Proc Natl Acad Sci U S A; 1989 Feb; 86(4):1372-6. PubMed ID: 2465552
[TBL] [Abstract][Full Text] [Related]
13. Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice.
Zhou X; Paulsson G; Stemme S; Hansson GK
J Clin Invest; 1998 Apr; 101(8):1717-25. PubMed ID: 9541503
[TBL] [Abstract][Full Text] [Related]
14. A natural antibody to oxidized cardiolipin binds to oxidized low-density lipoprotein, apoptotic cells, and atherosclerotic lesions.
Tuominen A; Miller YI; Hansen LF; Kesäniemi YA; Witztum JL; Hörkkö S
Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2096-102. PubMed ID: 16794225
[TBL] [Abstract][Full Text] [Related]
15. Definition of the immunogenic forms of modified human LDL recognized by human autoantibodies and by rabbit hyperimmune antibodies.
Virella G; Thorpe SR; Alderson NL; Derrick MB; Chassereau C; Rhett JM; Lopes-Virella MF
J Lipid Res; 2004 Oct; 45(10):1859-67. PubMed ID: 15258197
[TBL] [Abstract][Full Text] [Related]
16. Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: a biochemical signature of an enhanced in vivo low-density lipoprotein oxidation.
Maggi E; Marchesi E; Ravetta V; Martignoni A; Finardi G; Bellomo G
J Hypertens; 1995 Jan; 13(1):129-38. PubMed ID: 7759843
[TBL] [Abstract][Full Text] [Related]
17. Circulating autoantibodies to oxidized LDL correlate with arterial accumulation and depletion of oxidized LDL in LDL receptor-deficient mice.
Tsimikas S; Palinski W; Witztum JL
Arterioscler Thromb Vasc Biol; 2001 Jan; 21(1):95-100. PubMed ID: 11145939
[TBL] [Abstract][Full Text] [Related]
18. Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-I with severe hypercholesterolaemia.
Boullier A; Hennuyer N; Tailleux A; Furman C; Duverger N; Caillaud JM; Castro G; Fievet C; Fruchart JC; Duriez P
Clin Sci (Lond); 2001 Mar; 100(3):343-55. PubMed ID: 11222122
[TBL] [Abstract][Full Text] [Related]
19. Oxidation of high-density lipoprotein HDL3 leads to exposure of apo-AI and apo-AII epitopes and to formation of aldehyde protein adducts, and influences binding of oxidized low-density lipoprotein to type I and type III collagen in vitro1.
Greilberger J; Jürgens G
Biochem J; 1998 Apr; 331 ( Pt 1)(Pt 1):185-91. PubMed ID: 9512478
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies to OxLDL fail to alter the clearance of injected OxLDL in apolipoprotein E-deficient mice.
Reardon CA; Miller ER; Blachowicz L; Lukens J; Binder CJ; Witztum JL; Getz GS
J Lipid Res; 2004 Jul; 45(7):1347-54. PubMed ID: 15102879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
